相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhibition of amyloid-beta peptide aggregation rescues the autophagic deficits in the TgCRND8 mouse model of Alzheimer disease
Aaron Y. Lai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis
Jan Thoene et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
The Antiepileptic Drug Valproic Acid Restores T Cell Homeostasis and Ameliorates Pathogenesis of Experimental Autoimmune Encephalomyelitis
Jie Lv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Clinical trials in Alzheimer's disease': immunotherapy approaches
Julien Delrieu et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Adverse effects of antiepileptic drugs (vol 11, pg 792, 2012)
P. Perucca et al.
LANCET NEUROLOGY (2012)
Neuroprotective effects of valproic acid following transient global ischemia in rats
Aiguo Xuan et al.
LIFE SCIENCES (2012)
An epigenetic blockade of cognitive functions in the neurodegenerating brain
Johannes Graeff et al.
NATURE (2012)
Roles of AMP-activated Protein Kinase in Alzheimer's Disease
Zhiyou Cai et al.
NEUROMOLECULAR MEDICINE (2012)
Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment
Arnold Bakker et al.
NEURON (2012)
Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder
Andrew G. Foley et al.
NEUROPHARMACOLOGY (2012)
VALPROIC ACID INCREASES WHITE MATTER REPAIR AND NEUROGENESIS AFTER STROKE
X. S. Liu et al.
NEUROSCIENCE (2012)
VALPROIC ACID AMELIORATES INFLAMMATION IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS RATS
Z. Zhang et al.
NEUROSCIENCE (2012)
Topiramate Treatment Is Neuroprotective and Reduces Oligodendrocyte Loss after Cervical Spinal Cord Injury
John C. Gensel et al.
PLOS ONE (2012)
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
Pascal E. Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration
Eva-Maria Mandelkow et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Adverse effects of antiepileptic drugs
Piero Perucca et al.
LANCET NEUROLOGY (2012)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
Pierre N. Tariot et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Levetiracetam in brain ischemia: Clinical implications in neuroprotection and prevention of post-stroke epilepsy
Vincenzo Belcastro et al.
BRAIN & DEVELOPMENT (2011)
Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains
Jian-Quan Shi et al.
BRAIN RESEARCH (2011)
Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways
Jiang-Ping Hu et al.
BRAIN RESEARCH BULLETIN (2011)
Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneously epileptic rats
Sei Sugata et al.
BRAIN RESEARCH BULLETIN (2011)
Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels
Sofya Ziyatdinova et al.
EPILEPSY RESEARCH (2011)
Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation
Valerie Vingtdeux et al.
FASEB JOURNAL (2011)
Neuronal activity regulates the regional vulnerability to amyloid-β deposition
Adam W. Bero et al.
NATURE NEUROSCIENCE (2011)
Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain
D. L. Vogt et al.
NEUROBIOLOGY OF AGING (2011)
Autophagy failure in Alzheimer's disease-locating the primary defect
Ralph A. Nixon et al.
NEUROBIOLOGY OF DISEASE (2011)
Topiramate dose effects on cognition A randomized double-blind study
D. W. Loring et al.
NEUROLOGY (2011)
Chronic divalproex sodium use and brain atrophy in Alzheimer disease
A. S. Fleisher et al.
NEUROLOGY (2011)
TOPIRAMATE PROMOTES NEUROLOGICAL RECOVERY IN A NEW MODEL OF TRAUMATIC BRAIN INJURY IN RATS
K. Kouzounias et al.
NEUROSCIENCE (2011)
POTENTIAL AUTOPHAGY ENHANCERS ATTENUATE ROTENONE-INDUCED TOXICITY IN SH-SY5Y
N. Xiong et al.
NEUROSCIENCE (2011)
Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis
Je-Seong Won et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Valproic acid as a promising agent to combat Alzheimer's disease
Xiu-Zhen Zhang et al.
BRAIN RESEARCH BULLETIN (2010)
AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism
Valerie Vingtdeux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cognitive Effects of Topiramate in Migraine Patients Aged 12 Through 17 Years
Gahan J. Pandina et al.
PEDIATRIC NEUROLOGY (2010)
Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice
Shahaf Peleg et al.
SCIENCE (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Epilepsy and Cognitive Impairments in Alzheimer Disease
Jorge J. Palop et al.
ARCHIVES OF NEUROLOGY (2009)
Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy
Rimante Minkeviciene et al.
JOURNAL OF NEUROSCIENCE (2009)
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
Hong Qing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease
Jorge J. Palop et al.
NEURON (2007)
Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent
Christian Frisch et al.
EPILEPSY RESEARCH (2007)
Incidence and predictors of seizures in patients with Alzheimer's disease
JC Amatniek et al.
EPILEPSIA (2006)
Levetiracetam: Antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus
JE Gibbs et al.
EPILEPSIA (2006)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
The mechanism of neuroprotection by topiramate in an animal model of epilepsy
AP Kudin et al.
EPILEPSIA (2004)
The activity of antiepileptic drugs as histone deacetylase inhibitors
S Eyal et al.
EPILEPSIA (2004)
Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats
YQ Liu et al.
STROKE (2004)
RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier
R Deane et al.
STROKE (2004)
The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing
JA Tschäpe et al.
EMBO JOURNAL (2002)
Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia
E Hanon et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2001)